Delwedd Flaen

Miltefosine enhances infectivity of a miltefosine-resistant Leishmania infantum strain by attenuating its innate immune recognition.

<h4>Background</h4>Miltefosine (MIL) is currently the only oral drug available to treat visceral leishmaniasis but its use as first-line monotherapy has been compromised by an increasing treatment failure. Despite the scarce number of resistant clinical isolates, MIL-resistance by mutati...

Disgrifiad llawn

Wedi'i Gadw mewn:

Manylion Llyfryddiaeth
Prif Awduron:	Dimitri Bulté (Awdur), Lieselotte Van Bockstal (Awdur), Laura Dirkx (Awdur), Magali Van den Kerkhof (Awdur), Carl De Trez (Awdur), Jean-Pierre Timmermans (Awdur), Sarah Hendrickx (Awdur), Louis Maes (Awdur), Guy Caljon (Awdur)
Fformat:	Llyfr
Cyhoeddwyd:	Public Library of Science (PLoS), 2021-07-01T00:00:00Z.
Pynciau:	article
Mynediad Ar-lein:	Connect to this object online.
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg

Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum.
gan: Sarah Hendrickx, et al.
Cyhoeddwyd: (2017)

In-depth comparison of cell-based methodological approaches to determine drug susceptibility of visceral Leishmania isolates.
gan: Sarah Hendrickx, et al.
Cyhoeddwyd: (2019)

Effect of Clindamycin on Intestinal Microbiome and Miltefosine Pharmacology in Hamsters Infected with <i>Leishmania infantum</i>
gan: Ana Isabel Olías-Molero, et al.
Cyhoeddwyd: (2023)

Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging.
gan: Juliana Q Reimão, et al.
Cyhoeddwyd: (2015)

Complex cutaneous infection by Leishmania mexicana treated with miltefosine
gan: Rachel L. Sadowsky, BA, et al.
Cyhoeddwyd: (2022)

Fitness and Phenotypic Characterization of Miltefosine-Resistant Leishmania major.
gan: Kimbra G Turner, et al.
Cyhoeddwyd: (2015)

The effect of the sugar metabolism on Leishmania infantum promastigotes inside the gut of Lutzomyia longipalpis: A sweet relationship?
gan: Sarah Hendrickx, et al.
Cyhoeddwyd: (2022)

Synergistic Effects of Artesunate in Combination with Amphotericin B and Miltefosine against <i>Leishmania infantum</i>: Potential for Dose Reduction and Enhanced Therapeutic Strategies
gan: Nuchpicha Intakhan, et al.
Cyhoeddwyd: (2024)

Miltefosine for the treatment of cutaneous leishmaniasis-A pilot study from Ethiopia.
gan: Saskia van Henten, et al.
Cyhoeddwyd: (2021)

In Vitro Evaluation of the Combinatorial Effect of Naringenin and Miltefosine against <i>Leishmania amazonensis</i>
gan: Vinícius Lopes Lessa, et al.
Cyhoeddwyd: (2024)

Multiple mutations in heterogeneous miltefosine-resistant Leishmania major population as determined by whole genome sequencing.
gan: Adriano C Coelho, et al.
Cyhoeddwyd: (2012)

Miltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in Colombia.
gan: Olga Lucía Fernández, et al.
Cyhoeddwyd: (2014)

Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial.
gan: Paulo R Machado, et al.
Cyhoeddwyd: (2010)

Treatment of Schistosoma mansoni with miltefosine in vitro enhances serological recognition of defined worm surface antigens.
gan: Marwa H El-Faham, et al.
Cyhoeddwyd: (2017)

Successful treatment of multifocal cutaneous leishmaniasis with miltefosine
gan: Bhushan Madke, et al.
Cyhoeddwyd: (2011)

Availability of miltefosine for the treatment of kala-azar in India
gan: Shyam Sundar, et al.
Cyhoeddwyd: (2005)

Dynamics of parasite clearance in cutaneous leishmaniasis patients treated with miltefosine.
gan: Thomas P C Dorlo, et al.
Cyhoeddwyd: (2011)

Correction: Miltefosine and Antimonial Drug Susceptibility of Leishmania Viannia Species and Populations in Regions of High Transmission in Colombia
Cyhoeddwyd: (2014)

Unravelling the rate of action of hits in the Leishmania donovani box using standard drugs amphotericin B and miltefosine.
gan: Diana Tegazzini, et al.
Cyhoeddwyd: (2017)

Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial.
gan: Monique Wasunna, et al.
Cyhoeddwyd: (2016)

Use of miltefosine in the treatment of cutaneous leishmaniasis in French Guiana
gan: Charlene Oliveira, et al.
Cyhoeddwyd: (2024)

Chitosan nanoparticles improve the effectivity of miltefosine against Acanthamoeba.
gan: Alireza Latifi, et al.
Cyhoeddwyd: (2024)

Leishmania and HIV co-infection: first naturally Leishmania strain presenting decreased susceptibility to miltefosine, recovered from a patient in Portugal
gan: Ana Isabel Pinto, et al.
Cyhoeddwyd: (2024)

In vitro and in vivo miltefosine susceptibility of a Leishmania amazonensis isolate from a patient with diffuse cutaneous leishmaniasis.
gan: Adriano C Coelho, et al.
Cyhoeddwyd: (2014)

Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis.
gan: Vasundhra Bhandari, et al.
Cyhoeddwyd: (2012)

Glutamine supplementation improves the efficacy of miltefosine treatment for visceral leishmaniasis.
gan: Carolina Ferreira, et al.
Cyhoeddwyd: (2020)

Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress.
gan: Deepak Kumar Deep, et al.
Cyhoeddwyd: (2017)

In Vitro and In Vivo Miltefosine Susceptibility of a Leishmania amazonensis Isolate from a Patient with Diffuse Cutaneous Leishmaniasis: Follow-Up.
gan: Adriano C Coelho, et al.
Cyhoeddwyd: (2016)

Monitoring Cutaneous Leishmaniasis Lesions in Mice Undergoing Topical Miltefosine Treatment
gan: Laura Fernanda Neira, et al.
Cyhoeddwyd: (2023)

Post-kala-azar dermal leishmaniasis developing in miltefosine-treated visceral leishmaniasis
gan: Sankha Koley, et al.
Cyhoeddwyd: (2013)

Cutaneous Leishmaniasis Treated with Miltefosine: A Case Series of 10 Paediatric Patients
gan: Ayelet Ollech, et al.
Cyhoeddwyd: (2020)

Pharmacokinetic / pharmacodynamic relationships of liposomal amphotericin B and miltefosine in experimental visceral leishmaniasis.
gan: Andrew A Voak, et al.
Cyhoeddwyd: (2021)

A Luciferase-Expressing Leishmania braziliensis Line That Leads to Sustained Skin Lesions in BALB/c Mice and Allows Monitoring of Miltefosine Treatment Outcome.
gan: Adriano C Coelho, et al.
Cyhoeddwyd: (2016)

Comparison of cardiotoxicity between N-methyl-glucamine and miltefosine in the treatment of American cutaneous leishmaniasis
gan: Daniel Holanda Barroso, et al.
Cyhoeddwyd: (2021)

Correction: Miltefosine and Antimonial Drug Susceptibility of Species and Populations in Regions of High Transmission in Colombia.
Cyhoeddwyd: (2014)

Effectiveness of miltefosine in cutaneous leishmaniasis caused by Leishmania tropica in Pakistan after antimonial treatment failure or contraindications to first line therapy-A retrospective analysis.
gan: Suzette Kämink, et al.
Cyhoeddwyd: (2021)

The effect of oral miltefosine in treatment of antimoniate resistant anthroponotic cutaneous leishmaniasis: An uncontrolled clinical trial.
gan: Masoumeh Tayyebi, et al.
Cyhoeddwyd: (2021)

Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis.
gan: Brandon A Berger, et al.
Cyhoeddwyd: (2017)

Topical Sustained Delivery of Miltefosine Via Drug-Eluting Contact Lenses to Treat Acanthamoeba Keratitis
gan: Lin Chen, et al.
Cyhoeddwyd: (2022)

Glycoinositolphospholipids from Leishmania braziliensis and L. infantum: modulation of innate immune system and variations in carbohydrate structure.
gan: Rafael Ramiro Assis, et al.
Cyhoeddwyd: (2012)